Skip to main content

Nephros to Present at Three November Investment Conferences

Written by Customer Service on . Posted in Public Companies.

SOUTH ORANGE, NJ, Nov. 09, 2020 (GLOBE NEWSWIRE) — via NewMediaWire –Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will participate at the following investor conferences in November.
Virtual Fall Investor SummitNovember 16, 20209:30 AM ETWebcast link: https://www.webcaster4.com/Webcast/Page/2038/38365https://investorsummitgroup.com
Craig-Hallum Capital Group11th Annual Alpha Select ConferenceNovember 17, 2020Conference attendance is by invitation only: One-on-one and small group meetingshttps://www.craig-hallum.com/alpha-select/are-you-an-alpha-select-company/
Sidoti Virtual Microcap ConferenceNovember 19, 202011:30 AM ETWebcast link: https://sidoti.zoom.us/webinar/register/WN_zzc86blrTGe68lysJNbIfAhttps://sidoticonference.com
About NephrosNephros is a commercial-stage company that develops and markets high performance water purification products and pathogen detection systems for medical and commercial markets. Nephros ultrafilters are used in hospitals, medical clinics, and commercial facilities to retain bacteria – including Legionella and other pathogens – and viruses from water, providing an important aid in infection control for showers, sinks, and ice machines. Nephros ultrafilters are also used in dialysis centers to aid in the removal of endotoxins and other biological contaminants from water and bicarbonate concentrate in hemodialysis machines. Nephros pathogen detection systems, including the PluraPath™, SequaPath™, and DialyPath™ systems, provide data on water­borne biological content to medical and water quality professionals. Our products integrate Nephros ultrafilters with quantitative polymerase chain reaction (qPCR) technology to deliver actionable water pathogen information in real time.Nephros commercial filters, including AETHER™ brand filters, improve the taste and odor of water, and reduce scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets.For more information about Nephros, please visit its website at www.nephros.com.Investor Relations Contact:Kirin Smith, PresidentPCG Advisory, Inc.(646) 863-6519ksmith@pcgadvisory.comwww.pcgadvisory.com
Media Contact:Bill DouglassGotham Communications, LLC(646) 504-0890bill@gothamcomm.comwww.gothamcomm.com
Company Contact:Andy Astor, President and CEONephros, Inc.(201) 345-0824andy@nephros.comwww.nephros.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.